Press Room

Axichem is an innovative biotechnology company specialising in development of natural analogue, safe components.

Read more
All Press Releases
Financial Reports
News
SubscribePress Contact
Regulatory Press Releases
September 23, 2026
aXichem AB (publ) genomför en riktad emission i samband med utnyttjande av teckningsoptioner av serie TO2A
Styrelsen i aXichem AB (publ) ("aXichem" eller "Bolaget") har idag, Read the article here
September 23, 2026
aXichem AB (publ) carries out a directed share issue in connection with the exercise of warrants of series TO2A
The Board of Directors of aXichem AB (publ) ("aXichem" or Read the article here
September 21, 2026
aXichem meddelar utfallet från utnyttjandet av teckningsoptioner av serie TO2A
aXichem AB (publ) (“aXichem” eller “Bolaget”) meddelar idag utfallet från Read the article here
September 21, 2026
aXichem announces the outcome of the exercise of the warrants of series TO2A
aXichem AB (publ) ("aXichem" or the "Company") today announces the Read the article here
September 11, 2026
aXichem enters into agreements on non-compensated subscription undertakings totaling approximately SEK 2.6 million regarding ongoing redemption of warrants of series TO2A
aXichem AB (publ) ("aXichem" or the "Company") announces that the Read the article here
September 11, 2026
aXichem ingår avtal om vederlagsfria teckningsåtaganden om totalt cirka 2,6 MSEK avseende pågående inlösen av teckningsoptioner av serie TO2A
aXichem AB (publ) (“aXichem” eller “Bolaget”) meddelar att Bolaget ingått Read the article here
September 04, 2026
aXichem announces subscription price for TO2A, which can be exercised during the period 7 – 18 September 2026
The subscription price upon exercise of warrants of series TO2A Read the article here
September 04, 2026
aXichem meddelar teckningskurs för TO2A, som kan nyttjas under perioden 7 – 18 september 2026
Teckningskursen vid nyttjande teckningsoptioner av serie TO2A i aXichem AB Read the article here
August 27, 2026
aXichem AB (publ), Interim Report January – June 2026
aXichem’s development during the period 2026-01-01—2026-06-30 In this interim report, Read the article here
August 27, 2026
aXichem AB (publ), delårsrapport januari – juni 2026
aXichems utveckling under perioden 2026-01-01—2026-06-30 I denna delårsrapport presenteras koncernen Read the article here
July 24, 2026
aXichem får positivt vetenskapligt utlåtande från EFSA för phenylcapsaicin som salmonellahämmande tillsats i kycklingfoder
aXichem AB (publ), (aXichem), som utvecklar innovativa fodertillsatser och kosttillskottsingredienser, Read the article here
July 24, 2026
aXichem receives positive scientific opinion from EFSA for phenylcapsaicin as a salmonella-inhibiting additive in chicken feed
aXichem AB (publ), (aXichem), which develops innovative feed additives and Read the article here
June 17, 2026
Resolutions from the 2026 Annual General Meeting of aXichem AB (publ)
aXichem AB (publ), corporate registration number 556739-8663 (the “Company”), held Read the article here
June 17, 2026
Kommuniké från årsstämma 2026 i aXichem AB (publ)
aXichem AB (publ), org.nr 556739-8663 (”Bolaget”), höll årsstämma onsdagen den Read the article here
May 27, 2026
aXichem AB (publ) publicerar Årsredovisning 2025
aXichem AB (publ), som utvecklar innovativa naturanaloga fodertillsatser och kosttillskottsingredienser, Read the article here
May 27, 2026
aXichem AB (publ) publishes Annual Report 2025
aXichem AB (publ), the developer of innovative natural analogue feed Read the article here
May 21, 2026
aXichem AB (publ), delårsrapport januari – mars 2026
aXichems utveckling under perioden 2026-01-01—2026-03-31 I denna delårsrapport presenteras koncernen Read the article here
May 21, 2026
aXichem AB (publ), Interim Report January – March 2026
aXichem’s development during the period 2026-01-01—2026-03-31 In this interim report, Read the article here
May 15, 2026
KALLELSE TILL ÅRSSTÄMMA I AXICHEM AB (PUBL)
Aktieägarna i aXichem AB (publ) kallas till årsstämma onsdagen den Read the article here
May 15, 2026
NOTICE OF ANNUAL GENERAL MEETING IN AXICHEM AB (PUBL)
The shareholders in aXichem AB (publ) are hereby convened to Read the article here
March 18, 2026
aXichem erhåller produktregistrering i Brasilien för phenylcapsaicin som fodertillsats för mjölkkor och öppnar ett nytt marknadssegment
aXichem AB (publ), (aXichem), som utvecklar som utvecklar naturanaloga fodertillsatser Read the article here
March 18, 2026
aXichem obtains product registration in Brazil for phenylcapsaicin as a feed additive for dairy cattle and opens up a new market segment
aXichem AB (publ), (aXichem), a developer of innovative natural analogue Read the article here
March 10, 2026
aXichem genomför en riktad emission av units till garant i samband med den genomförda företrädesemissionen
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, HELT ELLER DELVIS, DIREKT Read the article here
March 10, 2026
aXichem carries out a directed issue of units to guarantor in connection with the completed rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN Read the article here
March 02, 2026
aXichem announces final outcome of the rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN Read the article here
March 02, 2026
aXichem offentliggör slutligt utfall i företrädesemissionen
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, HELT ELLER DELVIS, DIREKT Read the article here
February 27, 2026
aXichem announces preliminary outcome of the rights issue
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN Read the article here
February 27, 2026
aXichem offentliggör preliminärt utfall i företrädesemissionen
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, HELT ELLER DELVIS, DIREKT Read the article here
February 19, 2026
aXichem AB (publ), Bokslutskommuniké, januari – december 2025
aXichems utveckling under perioden 2025-01-01—2025-12-31 I denna delårsrapport presenteras koncernen Read the article here
February 19, 2026
aXichem AB (publ), Year End Report, January – December 2025
aXichem’s development during the period 2025-01-01—2025-12-31 In this interim report, Read the article here
February 03, 2026
aXichem genomför företrädesemission av units om cirka 11 MSEK
EJ FÖR OFFENTLIGGÖRANDE, PUBLICERING ELLER DISTRIBUTION, HELT ELLER DELVIS, DIREKT Read the article here
February 03, 2026
aXichem carries out a rights issue of units of approximately SEK 11 million
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN Read the article here
SubscribePress Contact